Results for tag: "Dermatomyositis Drug"

Dermatomyositis is an inflammatory disorder that affects the skin and muscles. Treatment for this condition typically involves a combination of medications, physical therapy, and lifestyle changes. Dermatological drugs are used to treat the skin symptoms of dermatomyositis, such as rash, itching, and inflammation. These drugs can include topical corticosteroids, calcineurin inhibitors, and immunosuppressants. Additionally, systemic medications, such as methotrexate, may be prescribed to reduce inflammation and improve muscle strength. The dermatomyositis drug market is composed of a variety of pharmaceutical companies that specialize in the development and manufacture of medications for this condition. These companies include AbbVie, Pfizer, Novartis, and Merck, among others. These companies are focused on providing innovative treatments to improve the quality of life for those living with dermatomyositis. Show Less Read more